12.11.2015 - Standard & Poor’s and Moody’s have both lowered their credit ratings for Anglo-Swedish drugs company AstraZeneca. Citing a negative outlook from the loss of patent protection on...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)